PEAK6
IBB icon

PEAK6’s iShares Biotechnology ETF IBB Stock Holding History

PEAK6’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$405K Sell
2,400
-200,500
-99% -$34.3M ﹤0.01% 2065
2025
Q4 		$34.2M Buy
202,900
+60,100
+42% +$9.76M 0.06% 243
2025
Q3 		$20.6M Buy
142,800
+100,000
+234% +$13.6M 0.03% 416
2025
Q2 		$5.41M Sell
42,800
-1,413,500
-97% -$174M 0.01% 913
2025
Q1 		$186M Sell
1,456,300
-199,200
-12% -$27M 0.42% 51
2024
Q4 		$219M Buy
+1,655,500
New +$233M 0.46% 42

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PEAK6's IBB Position: Q1 2026 in Review

PEAK6 opened a new position in iShares Biotechnology ETF (IBB) in Q1 2026: 3 shares worth $580. The stake represents ﹤0.01% of the portfolio and ranks #2616 among its holdings. This is a return to the name: PEAK6 previously reported a position in IBB as recently as Q4 2024.

PEAK6 first reported a position in IBB in Q4 2024 and has held it in 2 quarters since. The position peaked at $983K in Q4 2024. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • PEAK6 held 3 shares of iShares Biotechnology ETF worth $580 as of Q1 2026.
  • iShares Biotechnology ETF was a new PEAK6 position in Q1 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of PEAK6's portfolio in Q1 2026, its #2616 holding.
  • PEAK6 first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 2 quarters since.
  • PEAK6's iShares Biotechnology ETF position peaked at $983K in Q4 2024.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.